Skip to main content
SpringerLink
Log in

Thyroid disease and male reproductive function

  • Review Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Despite the high prevalence of thyroid diseases in the general population, male reproductive function in patients with thyroid disease has been the subject of only a few studies. Hyperthyroidism appears to cause sperm abnormalities (mainly reduction in motility), which reverse after restoration of euthyroidism. Radioiodine therapy for hyperthyroidism or thyroid cancer may cause transient reductions in sperm count and motility, but there appears to be little risk of permanent effects provided that the cumulative dose is less than 14 MBq. The effects of hypothyroidism on male reproduction appear to be more subtle than those of hyperthyroidism and reversible. Severe, prolonged hypothyroidism in childhood may be associated with permanent abnormalities in gonadal function.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Winters S.J., Berga S.L. Gonadal dysfunction in patients with thyroid disorders. Endocrinologist 1997, 7: 167–173.

    Article  Google Scholar 

  2. Shetty A., Wilber J.F. Pituitary-thyroid hormone interactions in states of hyper- and hypothyroidism: Clinical implications in 2000. Endocrinologist 2000, 10: 118–123.

    Article  Google Scholar 

  3. Jannini E.A., Ulisse S., D’Armiento M. Thyroid hormone and male gonadal function. Endocr. Rev. 1995, 16: 443–459.

    CAS  PubMed  Google Scholar 

  4. Jannini E.A., Crescenzi A., Rucci N., et al. Ontogenetic pattern of thyroid hormone receptor expression in the human testis. J. Clin. Endocrinol. Metab. 2000, 85: 3453–3457.

    Article  CAS  PubMed  Google Scholar 

  5. Olivo J., Southren A.L., Gordon G.G., Tochimoto S. Studies of the protein binding of testosterone in plasma in disorders of thyroid function: effect of therapy. J. Clin. Endocrinol. Metab. 1970, 31: 539–545.

    Article  CAS  PubMed  Google Scholar 

  6. Ruder H., Corvol P., Mahoudeau J.A., Ross G.T., Lipsett M.B. Effects of induced hyperthyroidism on steroid metabolism in man. J. Clin. Endocrinol. Metab. 1971, 33: 382–387.

    Article  CAS  PubMed  Google Scholar 

  7. Ford H.C., Cooke R.R., Keightley E.A., Feek C.M. Serum levels of free and bound testosterone in hyperthyroidism. Clin. Endocrinol. (Oxf.) 1992, 36: 187–192.

    Article  CAS  Google Scholar 

  8. Gordon G.G., Southren A.L., Tochimoto S., Rand J.J., Olivo J. Effect of hyperthyroidism and hypothyroidism on the metabolism of testosterone and androstenedione in man. J. Clin. Endocrinol. Metab. 1969, 29: 164–170.

    Article  CAS  PubMed  Google Scholar 

  9. Vermeulen A., Verdonck L., Van Der Straeten M., Orie N. Capacity of the testosterone-binding globulin in human plasma and influence of specific binding to testosterone on its metabolic clearance rate. J. Clin. Endocrinol. Metab. 1969; 29: 1470–1480.

    Article  CAS  Google Scholar 

  10. Kidd G.S., Glass A.R., Vigersky R.A. The hypothalamic-pituitary-testicular axis in thyrotoxicosis. J. Clin. Endocrinol. Metab. 1979, 48: 798–802.

    Article  CAS  PubMed  Google Scholar 

  11. Chopra I.J., Tulchinsky D. Status of estrogen-androgen balance in hyperthyroid men with Graves’ disease. J. Clin. Endocrinol. Metab. 1974, 38: 269–277.

    Article  CAS  PubMed  Google Scholar 

  12. Ridgway E.C., Maloof F., Longcope C. Androgen and oestrogen dynamics in hyperthyroidism. J. Endocrinol. 1982, 95: 105–115.

    Article  CAS  PubMed  Google Scholar 

  13. Gallagher T.F., Fukushima D.K., Noguchi S., et al. Recent studies in steroid hormone metabolism in man. Recent Prog. Horm. Res. 1966, 22: 283–303.

    CAS  PubMed  Google Scholar 

  14. Longcope C. Methods and results of aromatization studies in vivo. Cancer Res. 1982, 42 (8): 3307s-3311s.

    Google Scholar 

  15. Nomura K., Suzuki H., Saji M., et al. High serum progesterone in hyperthyroid men with Graves’ disease. J. Clin. Endocrinol. Metab. 1988, 66: 230–232.

    Article  CAS  PubMed  Google Scholar 

  16. Abalovich M., Levalle O., Hermes R., et al. Hypothalamicpituitary- testicular axis and seminal parameters in hyperthyroid males. Thyroid 1999, 9: 857–863.

    Article  CAS  PubMed  Google Scholar 

  17. Michnovicz J.J., Galbraith R.A. Effects of exogenous thyroxine on C-2 and C-16 alpha hydroxylations of estradiol in humans. Steroids 1990, 55: 22–26.

    Article  CAS  PubMed  Google Scholar 

  18. Carlson H.E. Current concepts — gynecomastia. N. Engl. J. Med. 1980, 303: 795–799.

    Article  CAS  PubMed  Google Scholar 

  19. Rojdmark S., Berg A., Kallner G. Hypothalamic-pituitarytesticular axis in patients with hyperthyroidism. Horm. Res. 1988, 29: 185–190.

    Article  CAS  PubMed  Google Scholar 

  20. Wortsman J., Rosner W., Dufau M.L. Abnormal testicular function in men with primary hypothyroidism. Am. J. Med. 1987, 82: 207–212.

    Article  CAS  PubMed  Google Scholar 

  21. Jaya Kumar B., Khurana M.L., Ammini A.C., Karmarkar M.G., Ahuja M.M. Reproductive endocrine functions in men with primary hypothyroidism: effect of thyroxine replacement. Horm. Res. 1990, 34: 215–218.

    Article  CAS  PubMed  Google Scholar 

  22. Velazquez E.M., Bellabarba Arata G. Effects of thyroid status on pituitary gonadotropin and testicular reserve in men. Arch. Androl. 1997, 38: 85–92.

    Article  CAS  PubMed  Google Scholar 

  23. Clyde H.R., Walsh P.C., English R.W. Elevated plasma testosterone and gonadotropin levels in infertile males with hyperthyroidism. Fertil. Steril. 1976, 27: 662–666.

    CAS  PubMed  Google Scholar 

  24. Hudson R.W., Edwards A.L. Testicular function in hyperthyroidism. J. Androl. 1992, 13: 117–124.

    CAS  PubMed  Google Scholar 

  25. Krassas G.E., Pontikides N., Deligianni V., Miras K. A prospective controlled study of the impact of hyperthyroidism on reproductive function in males. J. Clin. Endocrinol. Metab. 2002, 87: 3667–3671.

    Article  CAS  PubMed  Google Scholar 

  26. Dunn J.T. Choice of therapy in young adults with hyperthyroidism of Graves’ disease. A brief, case-directed poll of fiftyfour thyroidologists. Ann. Intern. Med. 1984, 100: 891–893.

    Article  CAS  PubMed  Google Scholar 

  27. Kaplan M.M., Meier D.A., Dworkin H.J. Treatment of hyperthyroidism with radioactive iodine. Endocrinol. Metab. Clin. North. Am. 1998, 27: 205–223.

    Article  CAS  PubMed  Google Scholar 

  28. Hyer S., Vini L., O’Connell M., Pratt B., Harmer C. Testicular dose and fertility in men following 131I therapy for thyroid cancer. Clin. Endocrinol. (Oxf.) 2002, 56: 755–758.

    Article  CAS  Google Scholar 

  29. Mussey R.D. The thyroid gland and pregnancy. Am. J. Obstet. Gynecol. 1938, 36: 529–538.

    Google Scholar 

  30. Krassas G.E. Thyroid disease and female reproduction. Fertil. Steril. 2000, 74: 1063–1070.

    Article  CAS  PubMed  Google Scholar 

  31. Handelsman D.J., Turtle J.R. Testicular damage after radioactive iodine (I-131) therapy for thyroid cancer. Clin. Endocrinol. (Oxf.) 1983, 18: 465–472.

    Article  CAS  Google Scholar 

  32. Starr P., Jaffe H.L., Oettinger L. Jr. Later results of 131-I treatment of hyperthyroidism in 73 children and adolescents: 1967 follow-up. J. Nucl. Med. 1969, 10: 586–590.

    CAS  PubMed  Google Scholar 

  33. Hayek A., Chapman E.M., Crawford J.D. Long-term results of treatment of thyrotoxicosis in children and adolescents with radioactive iodine. N. Engl. J. Med. 1970, 283: 949–953.

    Article  CAS  PubMed  Google Scholar 

  34. Safa A.M., Schumacher O.P., Rodriguez-Antunez A. Longterm follow-up results in children and adolescents treated with radioactive iodine (131-I) for hyperthyroidism. N. Engl. J. Med. 1975, 292: 167–171.

    Article  CAS  PubMed  Google Scholar 

  35. Halnan K.E. Risks from radioiodine treatment of thyrotoxicosis. Br. Med. J. 1983, 287: 1821–1822.

    Article  CAS  Google Scholar 

  36. Trunnell J.B., Duffy D.G., Godwin J.T., Peacock W., Kirschner L., Hill R. The distribution of radioactive iodine in human tissues: necropsy study in nine patients. J. Clin. Endocrinol. Metab. 1950, 10: 1007–1021.

    Article  CAS  PubMed  Google Scholar 

  37. Berman M., Braverman L.B., Burke J., et al. Iodine-123, iodine-124, iodine-125, iodine-126, iodine-130, iodine-131 and iodine-132 as sodium iodide MIRD pamphlet no 5. New York: The Society of Nuclear Medicine. 1988.

    Google Scholar 

  38. Erickson B.H. Effect of 60Co gamma radiation on the stem and differentiating spermatogonia of the postpuberal rat. Radiat. Res. 1976, 68: 433–448.

    Article  CAS  PubMed  Google Scholar 

  39. Mian T.A., Suzuki N., Glenn H.J., Haynie T.P., Meistrich M.L. Radiation damage to mouse testis cells from [99mTc] pertechnetate. J. Nucl. Med. 1977, 18: 1116–1122.

    CAS  PubMed  Google Scholar 

  40. Lushbaugh C.C., Casarett G.W. The effects of gonadal irradiation in clinical radiation therapy: a review. Cancer 1976, 37 (2): 1111–1125.

    Article  CAS  PubMed  Google Scholar 

  41. Gorman C.A. Radioiodine and pregnancy (Review). Thyroid 1999, 9: 721–726.

    Article  CAS  PubMed  Google Scholar 

  42. Handelsman D.J., Conway A.J., Donnelly P.E., Turtle J.R. Azoospermia after iodine-131 treatment for thyroid carcinoma. Br. Med. J. 1980, 281: 1527.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  43. Edmonds C.J., Smith T. The long-term hazards of the treatment of thyroid cancer with radioiodine. Br. J. Radiol. 1986, 59: 45–51.

    Article  CAS  PubMed  Google Scholar 

  44. Pacini F., Gasperi M., Fugazzola L., et al. Testicular function in patients with differentiated thyroid carcinoma treated with radioiodine. J. Nucl. Med. 1994, 35: 1418–1422.

    CAS  PubMed  Google Scholar 

  45. Wichers M., Benz E., Palmedo H., Biersack H.J., Grunwald F., Klingmuller D. Testicular function after radioiodine therapy for thyroid carcinoma. Eur. J. Nucl. Med. 2000, 27: 503–507.

    Article  CAS  PubMed  Google Scholar 

  46. Wartofsky L. Thyroid cancer. Humana Press, Totowa, New Jersey, 2000.

    Book  Google Scholar 

  47. Tunbridge W.M.G., Evered D., Hall R., et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin. Endocrinol. (Oxf.) 1977, 7: 481–493.

    Article  CAS  Google Scholar 

  48. Canaris G.J., Manowitz N.R., Mayor G., Ridgway E.C. The Colorado thyroid disease prevalence study. Arch. Intern. Med. 2000, 160: 526–534.

    Article  CAS  PubMed  Google Scholar 

  49. Delange F. The disorders induced by iodine deficiency. Thyroid 1994, 41: 107–128.

    Article  Google Scholar 

  50. Kolettis P.N., Sabanegh E.S. Significant medical pathology discovered during a male infertility evaluation. J. Urol. 2001, 166: 178–180.

    Article  CAS  PubMed  Google Scholar 

  51. Trummer H., Ramschak-Schwarzer S., Haas J., Habermann H., Pummer K., Leb G. Thyroid hormones and thyroid antibodies in infertile males. Fertil. Steril. 2001, 76: 254–257.

    Article  CAS  PubMed  Google Scholar 

  52. Vulsma T., Gons M.H., de Vijlder J.J.M. Maternal-fetal transfer of thyroxine in congenital hypothyroidism due to a total organification defect or thyroid agenesis. N. Engl. J. Med. 1989, 321: 13–16.

    Article  CAS  PubMed  Google Scholar 

  53. Longcope C. The male and female reproductive systems in hypothyroidism. In: Braverman L.E., Utiger R.D. (Eds.) Werner & Ingbar’s The thyroid: A fundamental and clinical text, 8th edition. Lippincott Williams & Wilkins, Philadelphia, 2000, P. 824.

    Google Scholar 

  54. Salerno M., Micillo M., Di Maio S., et al. Longitudinal growth, sexual maturation and final height in patients with congenital hypothyroidism detected by neonatal screening. Eur. J. Endocrinol. 2001, 145: 377–383.

    Article  CAS  PubMed  Google Scholar 

  55. Dickerman Z., De Vries L. Prepubertal and pubertal growth, timing and duration of puberty and attained adult height in patients with congenital hypothyroidism (CH) detected by the neonatal screening programme for CH — a longitudinal study. Clin. Endocrinol. (Oxf.) 1997, 47: 649–654.

    Article  CAS  Google Scholar 

  56. Hanna C.E., LaFranchi S.H. Adolescent thyroid disorders. Adolesc. Med. 2002, 13: 13–36.

    PubMed  Google Scholar 

  57. Kendle F. Case of precocious puberty in a female cretin. Br. Med. J. 1905, 1: 246–248.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  58. Panidis D.K., Rousso D.H. Macro-orchidism in juvenile hypothyroidism. Arch. Androl. 1999, 42: 85–87.

    Article  CAS  PubMed  Google Scholar 

  59. Grossman M., Weintraub B.D., Szkudlinski M.W. Novel insights into the molecular mechanisms of human thyrotropin action: structural, physiological, and therapeutic implications for the glycoprotein hormone family. Endocr. Rev. 1997, 18: 476–501.

    Article  Google Scholar 

  60. Corrales Hernandez J.J., Miralles Garcia J.M., Garcia Diez L.C. Primary hypothyroidism and human spermatogenesis. Arch. Androl. 1990, 25: 21–27.

    Article  CAS  PubMed  Google Scholar 

  61. Cavaliere H., Abelin N., Medeiros-Neto G. Serum levels of total testosterone and sex hormone binding globulin in hypothyroid patients and normal subjects treated with incremental doses of L-T4 or L-T3. J. Androl. 1988, 9: 215–219.

    CAS  PubMed  Google Scholar 

  62. Tagawa N., Takano T., Fukata S., et al. Serum concentration of androstenediol and androstenediol sulfate in patients with hyperthyroidism and hypothyroidism. Endocr. J. 2001, 48: 345–354.

    Article  CAS  PubMed  Google Scholar 

  63. Donnelly P., White C. Testicular dysfunction in men with primary hypothyroidism; reversal of hypogonadotrophic hypogonadism with replacement thyroxine. Clin. Endocrinol. (Oxf.) 2000, 52: 197–201.

    Article  CAS  Google Scholar 

  64. Horvath E., Kovacs K., Scheithauer B.W. Pituitary hyperplasia. Pituitary 1999, 1: 169–179.

    Article  CAS  PubMed  Google Scholar 

  65. Kocova M., Netkov S., Sukarova-Angelovska E. Pituitary pseudotumor with unusual presentation reversed shortly after the introduction of thyroxine replacement therapy. J. Pediatr. Endocrinol. Metab. 2001, 14: 1665–1669.

    Article  CAS  PubMed  Google Scholar 

  66. Honbo K.S., Van Herle A.J., Kellett K.A. Serum prolactin levels in untreated primary hypothyroidism. Am. J. Med. 1978, 64: 782–787.

    Article  CAS  PubMed  Google Scholar 

  67. Notsu K., Ito Y., Furuya H., Ohguni S., Kato Y. Incidence of hyperprolactinemia in patients with Hashimoto’s thyroiditis. Endocr. J. 1997, 44: 89–94.

    Article  CAS  PubMed  Google Scholar 

  68. Griboff S.I. Semen analysis in myxedema. Fertil. Steril. 1962, 13: 436–443.

    CAS  PubMed  Google Scholar 

  69. De la Balze E.A., Arrilaga F, Mancini R.E., Janches M., Davidson O.W., Gurtman A.I. Male hypogonadism in hypothyroidism: a study of six cases. J. Clin. Endocrinol. Metab. 1962, 22: 212–222.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Endocrinology and Metabolism, “Panagia” General Hospital, Thessaloniki, 546 22, Greece

    G. E. Krassas

  2. Endocrine Unit, Freeman Hospital, Newcastle upon Tyne, UK

    P. Perros

Authors
  1. G. E. Krassas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Perros
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to G. E. Krassas.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Krassas, G.E., Perros, P. Thyroid disease and male reproductive function. J Endocrinol Invest 26, 372–380 (2003). https://doi.org/10.1007/BF03345187

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03345187

Key-words

Search

Navigation